Yangtze River Pharmaceutical Group Co., Ltd
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 1dc05570d6
Drug names84First applicant · distinct drug namesAcceptance records127First applicant · distinct acceptance numbersUnder-review numbers7First applicant · current under-review listCo-applicant records59Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/12 06:41.
Drug filings
127 acceptance records as first applicant, grouped into 84 source drug names. Source data as of 2026/11/12 06:41.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2026/09/24
Supplement · 2
氯维地平乳状注射液 · No verified English name 1 records · Latest accepted 2026/09/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601804 | Supplement | 2026/09/23 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
YR-2316吸入粉雾剂 · No verified English name 2 records · Latest accepted 2026/08/13
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600994 | New drug | 2026/08/13 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2600993 | New drug | 2026/08/13 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | CDE ↗ |
Cetirizine Hydrochloride Tablets 2 records · Latest accepted 2026/07/16
Supplement · 2
10%脂肪乳(OO)/5.5%氨基酸(15)/葡萄糖(20%)注射液 · No verified English name 1 records · Latest accepted 2026/07/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601585 | Generic | 2026/07/03 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
瑞维那新吸入溶液 · No verified English name 1 records · Latest accepted 2026/07/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601556 | Generic | 2026/07/01 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Lansoprazole Enteric Capsules 1 records · Latest accepted 2026/05/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600865 | Supplement | 2026/05/07 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
泊沙康唑注射液 · No verified English name 2 records · Latest accepted 2026/03/12
Supplement · 1Generic · 1
盐酸妥诺达非片 · No verified English name 6 records · Latest accepted 2025/11/28
Supplement · 5New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502427 | Supplement | 2025/11/28 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CXHB2400166 | Supplement | 2024/07/30 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CXHB2400113 | Supplement | 2024/05/24 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CXHB2400069 | Supplement | 2024/03/20 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CXHB2400004 | Supplement | 2024/01/05 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CXHS2300035 | New drug | 2023/02/25 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Ganciclovir For Injection 2 records · Latest accepted 2025/11/06
Supplement · 2
Memantine Hydrochloride Tablets 1 records · Latest accepted 2025/10/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502097 | Supplement | 2025/10/17 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
酚麻美敏口服溶液 · No verified English name 1 records · Latest accepted 2025/09/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501905 | Supplement | 2025/09/25 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Safinamide Methansulfonate Tablets 2 records · Latest accepted 2025/08/14
Generic · 2
Esketamine Hydrochloride Injection 2 records · Latest accepted 2025/08/05
Supplement · 1Generic · 1
Diclofenac Potassium Tablets 1 records · Latest accepted 2025/03/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500447 | Supplement | 2025/03/06 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
美洛昔康纳米晶注射液 · No verified English name 2 records · Latest accepted 2025/03/05
Generic · 2
富马酸比索洛尔胶囊 · No verified English name 2 records · Latest accepted 2025/02/20
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500341 | Supplement | 2025/02/20 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2500340 | Supplement | 2025/02/20 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Peramivir Injection 2 records · Latest accepted 2025/01/14
Supplement · 1Generic · 1
Butorphanol Tartrate Injection 2 records · Latest accepted 2025/01/08
Generic · 2
阿瑞匹坦注射液 · No verified English name 1 records · Latest accepted 2025/01/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500016 | Generic | 2025/01/03 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Azacitidine For Injection 2 records · Latest accepted 2025/01/01
Supplement · 1Generic · 1
葡萄糖酸钙锌口服溶液 · No verified English name 1 records · Latest accepted 2024/12/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402144 | Supplement | 2024/12/14 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Ibuprofen Granules 1 records · Latest accepted 2024/11/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401997 | Supplement | 2024/11/27 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Levocetirizine dihydrochloride Oral Solution 1 records · Latest accepted 2024/11/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401998 | Supplement | 2024/11/27 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Memantine Hydrochloride Oral Solution 1 records · Latest accepted 2024/11/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401996 | Supplement | 2024/11/27 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Entecavir oral solution 1 records · Latest accepted 2024/11/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401939 | Supplement | 2024/11/21 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
盐酸氨溴索糖浆 · No verified English name 1 records · Latest accepted 2024/11/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401945 | Supplement | 2024/11/21 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Nicorandil for Injection 2 records · Latest accepted 2024/10/13
Supplement · 2
脂肪乳氨基酸(17)葡萄糖(19%)注射液 · No verified English name 1 records · Latest accepted 2024/08/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402566 | Generic | 2024/08/09 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution 1 records · Latest accepted 2024/05/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400608 | Supplement | 2024/05/10 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
琥珀酸地文拉法辛缓释片 · No verified English name 2 records · Latest accepted 2024/03/05
Generic · 2
Levofloxacin and Sodium Chloride Injection 2 records · Latest accepted 2024/02/02
Supplement · 2
西甲硅油乳剂 · No verified English name 1 records · Latest accepted 2024/01/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400227 | Generic | 2024/01/16 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
丁酸氯维地平乳状注射液 · No verified English name 1 records · Latest accepted 2023/12/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303461 | Generic | 2023/12/14 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Ethyl Iosapentate Capsules 1 records · Latest accepted 2023/12/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303326 | Generic | 2023/12/01 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Torsemide Injection 2 records · Latest accepted 2023/11/25
Supplement · 2
Iguratimod Tablets 2 records · Latest accepted 2023/11/14
Generic · 2
Diquafosol Sodium Eye Drops 2 records · Latest accepted 2023/09/26
Supplement · 1Generic · 1
盐酸左沙丁胺醇雾化吸入溶液 · No verified English name 3 records · Latest accepted 2023/09/05
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301989 | Supplement | 2023/09/05 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CYHB2301988 | Supplement | 2023/09/05 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CYHB2301987 | Supplement | 2023/09/05 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Lacosamide Oral Solution 1 records · Latest accepted 2023/07/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301704 | Supplement | 2023/07/29 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Levofloxacin Injection 1 records · Latest accepted 2023/07/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301646 | Supplement | 2023/07/20 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
泊马度胺胶囊 · No verified English name 2 records · Latest accepted 2023/07/12
Generic · 2
Carfilzomib For Injection 4 records · Latest accepted 2023/06/21
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301669 | Generic | 2023/06/21 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CYHS2301668 | Generic | 2023/06/21 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CYHL2100010 | Generic | 2021/01/27 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CYHL2100009 | Generic | 2021/01/27 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Cefalexin Capsules 1 records · Latest accepted 2023/06/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301342 | Supplement | 2023/06/16 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Anastrozole Tablets 1 records · Latest accepted 2023/06/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301294 | Supplement | 2023/06/07 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Cisatracurium Besylate Injection 4 records · Latest accepted 2023/05/17
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301078 | Supplement | 2023/05/17 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CYHB2301077 | Supplement | 2023/05/17 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CYHB2300268 | Supplement | 2023/02/11 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CYHB2300267 | Supplement | 2023/02/11 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Micafungin Sodium for Injection 1 records · Latest accepted 2023/05/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300993 | Supplement | 2023/05/09 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Omega-3-acid ethyl ester 90 Soft Capsules 1 records · Latest accepted 2023/02/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300357 | Generic | 2023/02/04 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Tafluprost Eye Drops 1 records · Latest accepted 2023/01/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300136 | Generic | 2023/01/14 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
百乐眠胶囊 · No verified English name 2 records · Latest accepted 2022/10/22
Supplement · 2
依托咪酯乳状注射液 · No verified English name 2 records · Latest accepted 2022/10/18
Generic · 2
注射用紫杉醇(白蛋白结合型) · No verified English name 1 records · Latest accepted 2022/09/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201544 | Generic | 2022/09/16 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
多索茶碱葡萄糖注射液 · No verified English name 1 records · Latest accepted 2022/07/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201293 | Supplement | 2022/07/28 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | CDE ↗ |
Bortezomib For Injection 1 records · Latest accepted 2022/07/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201186 | Supplement | 2022/07/15 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Dexrazoxane for Injection 1 records · Latest accepted 2022/05/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200705 | Generic | 2022/05/06 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
注射用盐酸达巴万星 · No verified English name 1 records · Latest accepted 2022/04/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2200027 | Generic | 2022/04/02 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Cefoxitin Sodium for Injection 1 records · Latest accepted 2022/03/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200432 | Supplement | 2022/03/10 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Tegafur，Gimeracil and Oteracil Potassium Capsules 2 records · Latest accepted 2021/12/22
Generic · 2
Vardenafil Hydrochloride Tablets 1 records · Latest accepted 2021/12/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102154 | Generic | 2021/12/07 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
地佐辛注射液 · No verified English name 2 records · Latest accepted 2021/12/01
Supplement · 2
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2021/07/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101406 | Generic | 2021/07/15 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
地氯雷他定口服溶液 · No verified English name 1 records · Latest accepted 2021/07/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101428 | Generic | 2021/07/12 | Yangtze River Pharmaceutical Group Co., Ltd; Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Lenalidomide Capsules 1 records · Latest accepted 2021/06/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101459 | Supplement | 2021/06/29 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Glipizide Controlled Tablets 1 records · Latest accepted 2021/06/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101303 | Generic | 2021/06/17 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
盐酸优克那非片 · No verified English name 1 records · Latest accepted 2021/06/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2101043 | Supplement | 2021/06/15 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Obeticholic Acid Tablets 2 records · Latest accepted 2021/06/09
Generic · 2
Dexmedetomidine Hydrochloride Injection 2 records · Latest accepted 2021/06/01
Supplement · 2
参蛇花痔疮膏 · No verified English name 1 records · Latest accepted 2021/05/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2101140 | Supplement | 2021/05/21 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Regorafenib Tablets 1 records · Latest accepted 2021/04/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101075 | Generic | 2021/04/19 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
YR-1702注射液 · No verified English name 1 records · Latest accepted 2021/04/16
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2101038 | New drug | 2021/04/16 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
散风通窍滴丸 · No verified English name 1 records · Latest accepted 2021/04/16
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZL2101005 | New drug | 2021/04/16 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
欧米加-3-酸乙酯90软胶囊 · No verified English name 1 records · Latest accepted 2021/04/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101042 | Generic | 2021/04/10 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Vecuronium Bromide For Injection 1 records · Latest accepted 2021/04/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150522 | Supplement | 2021/04/07 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Ranolazine Prolonged-Release Tablets 2 records · Latest accepted 2021/04/01
Generic · 2
Pemetrexed Disodium for Injection 3 records · Latest accepted 2021/03/23
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101043 | Supplement | 2021/03/23 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CYHB2101042 | Supplement | 2021/03/23 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| CYHB2101041 | Supplement | 2021/03/23 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
蓝芩口服液 · No verified English name 2 records · Latest accepted 2021/02/09
Supplement · 2
Vortioxetine Hydrobromide Tablets 2 records · Latest accepted 2021/02/05
Generic · 2
Bivalirudin for Injection 1 records · Latest accepted 2021/01/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100132 | Generic | 2021/01/29 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Delafloxacin for Injection 1 records · Latest accepted 2021/01/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2100004 | Generic | 2021/01/23 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Pramipexole Dihydrochloride Prolonged-release Tablets 1 records · Latest accepted 2021/01/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100065 | Generic | 2021/01/15 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Cefoperazone Sodium and Sulbactam Sodium for Injection 1 records · Latest accepted 2021/01/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150019 | Supplement | 2021/01/11 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Lenvatinib Mesilate Capsules 1 records · Latest accepted 2021/01/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100029 | Generic | 2021/01/11 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
柏艾胶囊 · No verified English name 1 records · Latest accepted 2021/01/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2012938 | Supplement | 2021/01/05 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
注射用雷贝拉唑钠 · No verified English name 1 records · Latest accepted 2018/05/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS1700455 | Generic | 2018/05/07 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Changes in the last 90 days
10 events from 2026/08/15 to 2026/11/12. CDE data as of 2026/11/12 06:41; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Marketing application approved: 1 applicationAccepted: 3 applicationsNo longer listed under review: 4 applicationsSupplement delivery: 2 applications
- 2026/10/30No longer listed under review
YR-2316吸入粉雾剂 · No verified English name
CXHL2600994
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2026/08/13
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/30No longer listed under review
YR-2316吸入粉雾剂 · No verified English name
CXHL2600993
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2026/08/13
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/26Marketing application approved
阿瑞匹坦注射液 · No verified English name
CYHS2500016 · 国药准字H20266411
Fact date: 2026/10/26 · Publication date: 2026/10/27 · Site observation date: 2026/11/03
View source · Table row 25 ↗ - 2026/10/24No longer listed under review
Vonoprazan Fumarate Tablets
CYHB2601812
Fact date: 2026/10/24 · Site observation date: 2026/10/24
Accepted: 2026/09/24
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/22); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 31
NMPA · Table row 31 ↗ View source ↗ - 2026/10/24No longer listed under review
Vonoprazan Fumarate Tablets
CYHB2601811
Fact date: 2026/10/24 · Site observation date: 2026/10/24
Accepted: 2026/09/24
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/22); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 30
NMPA · Table row 30 ↗ View source ↗ - 2026/10/22Supplement delivery
Vonoprazan Fumarate Tablets
CYHB2601812
Fact date: 2026/10/22 · Publication date: 2026/10/23 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 31 ↗ - 2026/10/22Supplement delivery
Vonoprazan Fumarate Tablets
CYHB2601811
Fact date: 2026/10/22 · Publication date: 2026/10/23 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 30 ↗ - 2026/09/24Accepted
Vonoprazan Fumarate Tablets
CYHB2601812
Fact date: 2026/09/24 · Site observation date: 2026/10/22
View source ↗ - 2026/09/24Accepted
Vonoprazan Fumarate Tablets
CYHB2601811
Fact date: 2026/09/24 · Site observation date: 2026/10/22
View source ↗ - 2026/09/23Accepted
氯维地平乳状注射液 · No verified English name
CYHB2601804
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗
Under review
7 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/12 06:41.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 氯维地平乳状注射液 · No verified English name | CYHB2601804 | Supplement | 2026/09/23 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Cetirizine Hydrochloride Tablets | CYHB2601355 | Supplement | 2026/07/16 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 10%脂肪乳(OO)/5.5%氨基酸(15)/葡萄糖(20%)注射液 · No verified English name | CYHS2601585 | Generic | 2026/07/03 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 瑞维那新吸入溶液 · No verified English name | CYHS2601556 | Generic | 2026/07/01 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Safinamide Methansulfonate Tablets | CYHS2502946 | Generic | 2025/08/14 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Safinamide Methansulfonate Tablets | CYHS2502945 | Generic | 2025/08/14 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 注射用雷贝拉唑钠 · No verified English name | CYHS1700455 | Generic | 2018/05/07 | Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
Catalogue holder records
83 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/12 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Butorphanol Tartrate Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20266044 | 2026/09/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Butorphanol Tartrate Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20266045 | 2026/09/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 美洛昔康注射液(III) · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20265000 | 2026/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carfilzomib For Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20264789 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carfilzomib For Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20264788 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 脂肪乳氨基酸(17)葡萄糖(19%)注射液 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20263895 | 2026/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 琥珀酸地文拉法辛缓释片 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20263242 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 琥珀酸地文拉法辛缓释片 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20263241 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esketamine Hydrochloride Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20258255 | 2025/11/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 氯维地平乳状注射液 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20255474 | 2025/09/16 | Not stated by source | CDE ↗ |
| Ethyl Iosapentate Capsules | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20254982 | 2025/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 泊马度胺胶囊 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20253720 | 2025/03/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 泊马度胺胶囊 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20253721 | 2025/03/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iguratimod Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20253637 | 2025/03/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Omega-3-acid ethyl ester 90 Soft Capsules | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20249504 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 依托咪酯中/长链脂肪乳注射液 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20249023 | 2024/10/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esketamine Hydrochloride Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20244027 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tegafur，Gimeracil and Oteracil Potassium Capsules | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20243202 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tegafur，Gimeracil and Oteracil Potassium Capsules | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20243203 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dexrazoxane for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20234637 | 2023/12/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 比卡鲁胺片 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20234422 | 2023/10/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 泊沙康唑注射液 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20234096 | 2023/09/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Peramivir Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233886 | 2023/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vardenafil Hydrochloride Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233768 | 2023/06/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate Capsules | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233638 | 2023/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Glipizide Controlled Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233470 | 2023/04/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefaclor Sustained Release Tablets（Ⅱ） | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233273 | 2023/03/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azacitidine For Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233219 | 2023/02/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233155 | 2023/02/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Regorafenib Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20223937 | 2022/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20223869 | 2022/11/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lenvatinib Mesilate Capsules | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20223803 | 2022/11/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Micafungin Sodium for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20223683 | 2022/09/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tenofovir alafenamide Fumarate Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20223579 | 2022/08/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bivalirudin for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20223462 | 2022/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitafloxacin Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20223425 | 2022/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vecuronium Bromide For Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20066941 | 2022/05/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sugammadex Sodium Injection | Yangtze River Pharmaceutical Group Co., Ltd | Jiangsu Hai An Pharma Co., Ltd. romanized | 国药准字H20223224 | 2022/04/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sugammadex Sodium Injection | Yangtze River Pharmaceutical Group Co., Ltd | Jiangsu Hai An Pharma Co., Ltd. romanized | 国药准字H20223225 | 2022/04/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tedizolid Phosphate For Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20223187 | 2022/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nifedipine Controlled-release Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20223165 | 2022/03/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tigecycline for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20183198 | 2022/02/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Bendamustine Hydrochloride For Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213967 | 2021/12/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dexmedetomidine Hydrochloride Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213921 | 2021/12/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Risedronate Sodium Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20080235 | 2021/11/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Docetaxel Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213630 | 2021/08/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Docetaxel Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213629 | 2021/08/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gemcitabine Hydrochloride for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20183460 | 2021/07/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Afatinib Dimaleate Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213524 | 2021/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Afatinib Dimaleate Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213523 | 2021/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Afatinib Dimaleate Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213525 | 2021/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Afatinib Dimaleate Tablets | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213526 | 2021/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 厄多司坦胶囊 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213487 | 2021/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 二甲双胍维格列汀片(II) · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213447 | 2021/06/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Sodium for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20183375 | 2021/05/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lenalidomide Capsules | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213276 | 2021/04/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ganciclovir For Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20053363 | 2021/02/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Moxifloxacin Hydrochloride And Sodium Chloride Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20193112 | 2021/02/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Raltitrexed for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213097 | 2021/02/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iohexol Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H10970358 | 2021/01/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iohexol Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H10970327 | 2021/01/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iohexol Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20103635 | 2021/01/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iohexol Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H10970326 | 2021/01/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Propofol Medium And Long Chain Fat Emulsion Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213014 | 2021/01/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Propofol Medium And Long Chain Fat Emulsion Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213013 | 2021/01/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Propofol Medium And Long Chain Fat Emulsion Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20213012 | 2021/01/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ceftazidime for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20043856 | 2020/12/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20043855 | 2020/12/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iodixanol Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20184001 | 2020/12/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iodixanol Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20184002 | 2020/12/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pemetrexed Disodium for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20184131 | 2020/12/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pemetrexed Disodium for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20143380 | 2020/12/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pemetrexed Disodium for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20143379 | 2020/12/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fluconazole and Sodium Chloride Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H32024251 | 2020/11/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Paclitaxel Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20058719 | 2020/11/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Paclitaxel Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20053001 | 2020/11/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iodixanol Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20143309 | 2020/11/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iodixanol Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20143310 | 2020/11/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoxitin Sodium for Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20057973 | 2020/11/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pantoprazole Sodium For Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H19990170 | 2020/10/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lenalidomide Capsules | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20203291 | 2020/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 吉非替尼片 · No verified English name | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20203219 | 2020/05/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Docetaxel Injection | Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20093850 | 2009/08/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/12 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
59 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/12 06:41.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 杞菊地黄口服液 · No verified English name | CYZB2605536 | Supplement | 2026/11/06 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Colistimethate Sodium for Injection | CYHS2602551 | Generic | 2026/10/16 | NANJING ZENKOM PHARMACEUTICAL CO.,LTD.; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 羚芎胶囊 · No verified English name | CYZB2605027 | Supplement | 2026/10/08 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 金胆片 · No verified English name | CYZB2604734 | Supplement | 2026/09/16 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Lacosamide Injection | CYHB2601447 | Supplement | 2026/07/28 | Jiangsu Hai An Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 五虎丹胶囊 · No verified English name | CYZB2602817 | Supplement | 2026/06/22 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 蓝芩口服液 · No verified English name | CYZB2600516 | Supplement | 2026/02/07 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 蓝芩口服液 · No verified English name | CYZB2600514 | Supplement | 2026/02/07 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Ioversol Injection | CYHS2600254 | Generic | 2026/01/22 | Fujian Sen Fu Run Pharmaceuticals Technology Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Ioversol Injection | CYHS2504040 | Generic | 2025/11/22 | Fujian Sen Fu Run Pharmaceuticals Technology Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 注射用磷酸左奥硝唑酯二钠 · No verified English name | CYHB2502298 | Supplement | 2025/11/06 | Yang Zi Jiang Pharma Group Jiangsu Zi Long Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 散风通窍滴丸 · No verified English name | CYZB2502049 | Supplement | 2025/09/17 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Letermovir Injection | CYHS2501343 | Generic | 2025/04/08 | Shanghai Xin Feng Pharmaceutical Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 明珠口服液 · No verified English name | CYZB2500543 | Supplement | 2025/03/29 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 五虎丹胶囊 · No verified English name | CYZB2500259 | Supplement | 2025/02/17 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 蛇胆川贝液 · No verified English name | CYZB2500236 | Supplement | 2025/02/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 明珠口服液 · No verified English name | CYZB2500235 | Supplement | 2025/02/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 柏艾胶囊 · No verified English name | CYZB2500211 | Supplement | 2025/01/27 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 蓝芩口服液 · No verified English name | CYZB2302294 | Supplement | 2023/11/17 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 蓝芩口服液 · No verified English name | CYZB2302293 | Supplement | 2023/11/17 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 注射用磷酸左奥硝唑酯二钠 · No verified English name | CYHB2300837 | Supplement | 2023/04/21 | Yang Zi Jiang Pharma Group Jiangsu Zi Long Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 羚芎胶囊 · No verified English name | CYZB2201105 | Supplement | 2022/09/20 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| YZJT-1705注射液 · No verified English name | CXHL2200539 | New drug | 2022/07/27 | Zhongguo Ke College Shanghai Drug Research Institute romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 益心颗粒 · No verified English name | CYZB2200014 | Supplement | 2022/01/10 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Terbinafine Hydrochloride Cream | CYHB2102454 | Supplement | 2021/12/28 | Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 咪喹莫特乳膏 · No verified English name | CYHB2102453 | Supplement | 2021/12/28 | Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Tretinoin Cream | CYHB2102452 | Supplement | 2021/12/28 | Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 那氟沙星乳膏 · No verified English name | CYHB2102451 | Supplement | 2021/12/28 | Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 利拉萘酯乳膏 · No verified English name | CYHB2102450 | Supplement | 2021/12/28 | Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 醋酸曲安奈德益康唑乳膏 · No verified English name | CYHB2102449 | Supplement | 2021/12/28 | Yang Zi Jiang Pharma Group Jiangsu Pharmaceutical Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 盐酸莫西沙星注射液 · No verified English name | CYHB2102061 | Supplement | 2021/11/01 | Jiangsu Hai An Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 固本咳喘片 · No verified English name | CYZB2101678 | Supplement | 2021/09/16 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 三七伤药片 · No verified English name | CYZB2101311 | Supplement | 2021/07/13 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 清凉喉片 · No verified English name | CYZB2101310 | Supplement | 2021/07/13 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 肝康颗粒 · No verified English name | CYZB2101313 | Supplement | 2021/07/12 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 杞菊地黄口服液 · No verified English name | CYZB2101308 | Supplement | 2021/07/12 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 麦味地黄口服液 · No verified English name | CYZB2101307 | Supplement | 2021/07/12 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 连榆烧伤膏 · No verified English name | CYZB2101306 | Supplement | 2021/07/12 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 清平颗粒 · No verified English name | CYZB2101305 | Supplement | 2021/07/12 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 参蛇花痔疮膏 · No verified English name | CYZB2101304 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 羚芎胶囊 · No verified English name | CYZB2101299 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 小儿珍贝散 · No verified English name | CYZB2101298 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 生脉饮 · No verified English name | CYZB2101297 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 银杏叶片 · No verified English name | CYZB2101295 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 银杏叶片 · No verified English name | CYZB2101294 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 金胆片 · No verified English name | CYZB2101293 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 益母草颗粒 · No verified English name | CYZB2101292 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 灯盏花素分散片 · No verified English name | CYZB2101291 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 首乌延寿片 · No verified English name | CYZB2101289 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 珍合灵片 · No verified English name | CYZB2101288 | Supplement | 2021/07/09 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 散风通窍滴丸 · No verified English name | CYZB2101286 | Supplement | 2021/07/08 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 盐酸左沙丁胺醇雾化吸入溶液 · No verified English name | CYHS2101271 | Generic | 2021/06/08 | Yang Zi Jiang Pharma Group Jiangsu Zi Long Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 盐酸左沙丁胺醇雾化吸入溶液 · No verified English name | CYHS2101270 | Generic | 2021/06/08 | Yang Zi Jiang Pharma Group Jiangsu Zi Long Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 西园喉药散(喷剂) · No verified English name | CYZB2101027 | Supplement | 2021/04/12 | Yang Zi Jiang Pharma Group Jiangsu Long Feng Tang Zhong Yao Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Torsemide Injection | CYHS2100309 | Generic | 2021/04/02 | Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Voriconazole for Injection | CYHS2100195 | Generic | 2021/02/19 | Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 盐酸左沙丁胺醇雾化吸入溶液 · No verified English name | CYHS2100177 | Generic | 2021/02/09 | Yang Zi Jiang Pharma Group Jiangsu Zi Long Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| 醋酸艾司利卡西平片 · No verified English name | CYHS2100147 | Generic | 2021/02/05 | Yang Zi Jiang Pharma Group Beijing Hai Yan Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
| Torsemide Injection | CYHS2000959 | Generic | 2021/01/01 | Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized; Yangtze River Pharmaceutical Group Co., Ltd | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/12 06:41
- Chemical-drug catalogue
- Last successful update: 2026/11/12 06:38
- Full API register
- Last successful update: 2026/11/12 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.